# This is a Single Ascending Dose Tolerance Study

> **NCT01133574** · PHASE1 · TERMINATED · sponsor: **Abbott** · enrollment: 47 (actual)

## Conditions studied

- Cognition Disorders

## Interventions

- **DRUG:** SLV354 capsules
- **DRUG:** SLV354 capsules
- **DRUG:** SLV354 capsules
- **DRUG:** SLV354 capsules
- **DRUG:** SLV354 capsules
- **DRUG:** SLV354 capsules
- **DRUG:** SLV354 capsules
- **DRUG:** SLV354 capsules
- **DRUG:** Placebo capsules
- **DRUG:** SLV354 capsules
- **DRUG:** SLV354 capsules
- **DRUG:** SLV354 capsules
- **DRUG:** SLV354 capsules
- **DRUG:** Placebo capsules

## Key facts

- **NCT ID:** NCT01133574
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 47 (ACTUAL)
- **Why stopped:** Part A completed successfully 22 July 2010, Part B will be separate PET study
- **Last updated:** 2011-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01133574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01133574, "This is a Single Ascending Dose Tolerance Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01133574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*